Dody Avichezer

795 total citations
21 papers, 639 citations indexed

About

Dody Avichezer is a scholar working on Immunology, Molecular Biology and Ophthalmology. According to data from OpenAlex, Dody Avichezer has authored 21 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 10 papers in Molecular Biology and 7 papers in Ophthalmology. Recurrent topics in Dody Avichezer's work include Glycosylation and Glycoproteins Research (7 papers), Ocular Diseases and Behçet’s Syndrome (6 papers) and Systemic Lupus Erythematosus Research (5 papers). Dody Avichezer is often cited by papers focused on Glycosylation and Glycoproteins Research (7 papers), Ocular Diseases and Behçet’s Syndrome (6 papers) and Systemic Lupus Erythematosus Research (5 papers). Dody Avichezer collaborates with scholars based in Israel, United States and United Kingdom. Dody Avichezer's co-authors include Rachel R Caspi, Phyllis B. Silver, Barbara Wiggert, Nechama Gilboa‐Garber, Ruth Arnon, Bilha Schechter, N. Garber, Don J. Katcoff, Chi-Chao Chan and Larry A. Donoso and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Dody Avichezer

21 papers receiving 632 citations

Peers

Dody Avichezer
Bruce A. Boswell United States
Cornelia Oetke United Kingdom
John Steven United Kingdom
Cuiyan Tan United States
Shruti Shukla United States
Andrea Naranjo United States
Bruce A. Boswell United States
Dody Avichezer
Citations per year, relative to Dody Avichezer Dody Avichezer (= 1×) peers Bruce A. Boswell

Countries citing papers authored by Dody Avichezer

Since Specialization
Citations

This map shows the geographic impact of Dody Avichezer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dody Avichezer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dody Avichezer more than expected).

Fields of papers citing papers by Dody Avichezer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dody Avichezer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dody Avichezer. The network helps show where Dody Avichezer may publish in the future.

Co-authorship network of co-authors of Dody Avichezer

This figure shows the co-authorship network connecting the top 25 collaborators of Dody Avichezer. A scholar is included among the top collaborators of Dody Avichezer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dody Avichezer. Dody Avichezer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cortes, Lizette M., Dody Avichezer, Phyllis B. Silver, et al.. (2008). Inhibitory peptide analogs derived from a major uveitogenic epitope protect from antiretinal autoimmunity by inducing type 2 and regulatory T cells. Journal of Leukocyte Biology. 84(2). 577–585. 10 indexed citations
2.
Pennesi, Giuseppina, Mary J. Mattapallil, Dody Avichezer, et al.. (2003). A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice. Journal of Clinical Investigation. 111(8). 1171–1180. 74 indexed citations
3.
Pennesi, Giuseppina, Mary J. Mattapallil, Dody Avichezer, et al.. (2003). A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice. Journal of Clinical Investigation. 111(8). 1171–1180. 4 indexed citations
4.
Avichezer, Dody, Rafael S. Grajewski, Chi-Chao Chan, et al.. (2003). An Immunologically Privileged Retinal Antigen Elicits Tolerance. The Journal of Experimental Medicine. 198(11). 1665–1676. 64 indexed citations
5.
Avichezer, Dody, Gregory I. Liou, Chi-Chao Chan, et al.. (2003). Interphotoreceptor retinoid-binding protein (IRBP)-deficient C57BL/6 mice have enhanced immunological and immunopathogenic responses to IRBP and an altered recognition of IRBP epitopes. Journal of Autoimmunity. 21(3). 185–194. 23 indexed citations
6.
Avichezer, Dody, et al.. (2000). Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype.. PubMed. 41(1). 127–31. 103 indexed citations
7.
Avichezer, Dody, et al.. (2000). Residues 1–20 of IRBP and Whole IRBP Elicit Different Uveitogenic and Immunological Responses in Interferon Gamma Deficient Mice. Experimental Eye Research. 71(2). 111–118. 38 indexed citations
8.
Nishimura, Michael I., Dody Avichezer, Mary Custer, et al.. (1999). MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyte.. PubMed. 59(24). 6230–8. 68 indexed citations
9.
Avichezer, Dody, Bilha Schechter, & Ruth Arnon. (1998). Functional polymers in drug delivery: carrier-supported CDDP (cis-platin) complexes of polycarboxylates — effect on human ovarian carcinoma. Reactive and Functional Polymers. 36(1). 59–69. 43 indexed citations
10.
Avichezer, Dody, Georg F. Springer, Bilha Schechter, & Ruth Arnon. (1997). Immunoreactivities of polyclonal and monoclonal anti-T and anti-Tn antibodies with human carcinoma cells, grownin vitro and in a xenograft model. International Journal of Cancer. 72(1). 119–127. 44 indexed citations
11.
Avichezer, Dody, Georg F. Springer, Bilha Schechter, & Ruth Arnon. (1997). Immunoreactivities of polyclonal and monoclonal anti‐T and anti‐Tn antibodies with human carcinoma cells, grown in vitro and in a xenograft model. International Journal of Cancer. 72(1). 119–127. 2 indexed citations
13.
Grant, George, Susan Bardócz, S. W. B. Ewen, et al.. (1995). PurifiedPseudomonas aeruginosaPA-I lectin induces gut growth when orally ingested by rats. FEMS Immunology & Medical Microbiology. 11(3). 191–195. 13 indexed citations
14.
Avichezer, Dody, et al.. (1994). Pseudomonas aeruginosa PA-I lectin gene molecular analysis and expression in Escherichia coli. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1218(1). 11–20. 15 indexed citations
15.
Avichezer, Dody, Don J. Katcoff, N. Garber, & Nechama Gilboa‐Garber. (1992). Analysis of the amino acid sequence of the Pseudomonas aeruginosa galactophilic PA-I lectin. Journal of Biological Chemistry. 267(32). 23023–23027. 45 indexed citations
16.
Avichezer, Dody & Nechama Gilboa‐Garber. (1991). Antitumoral effects of Pseudomonas aeruginosa lectins on Lewis lung carcinoma cells cultured in vitro without and with murine splenocytes. Toxicon. 29(11). 1305–1313. 11 indexed citations
18.
Leibovici, Judith, Dody Avichezer, & Nechama Gilboa‐Garber. (1987). Effect of lectins on tumorigenicity of AKR lymphoma cells of varying malignancy.. PubMed. 6(6). 1411–5. 11 indexed citations
19.
Avichezer, Dody & Nechama Gilboa‐Garber. (1987). PA‐II, the L‐fucose and D‐mannose binding lectin of Pseudomonas aeruginosa stimulates human peripheral lymphocytes and murine splenocytes. FEBS Letters. 216(1). 62–66. 16 indexed citations
20.
Gilboa‐Garber, Nechama, Abraham J. Susswein, L. Mizrahi, & Dody Avichezer. (1985). Purification and characterization of the gonad lectin of Aplysia depilans. FEBS Letters. 181(2). 267–270. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026